logo
Select company
Select metric
$ 7.43MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
62
Sector
72
Industry
74
History
100
$ 6.58Close
$ 3.79 - $ 11.7 52-Week Range
Ticker Information

Ticker

CSBR

Company Name

CHAMPIONS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CHAMPIONS ONCOLOGY INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CSBR - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 7.43M
3/31/2025$ 7.17M
12/31/2024$ -1.27M
9/30/2024$ -2.76M
6/30/2024$ -1.98M
3/31/2024$ -7.5M
12/31/2023$ -7.18M
9/30/2023$ -5.31M
6/30/2023$ -3.19M
3/31/2023$ 1.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CHAMPIONS ONCOLOGY INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 5.77M.
  • Over the past 5 years, CHAMPIONS ONCOLOGY INC's average CF - Chg. Cash has been $ 235.75K.
  • The median CF - Chg. Cash for CHAMPIONS ONCOLOGY INC during this period was $ -77.5K
  • CHAMPIONS ONCOLOGY INC reached its highest CF - Chg. Cash over the past 5 years at $ 7.43M.
  • The lowest CF - Chg. Cash recorded by CHAMPIONS ONCOLOGY INC in the same timeframe $ -7.5M

CHAMPIONS ONCOLOGY INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
PLX : PROTALIX BIOTHERAPEUTICS INC $ -5.5MCELU : CELULARITY INC $ 382KSPRO : SPERO THERAPEUTICS INC $ -32.33MTHTX : THERATECHNOLOGIES INC $ -15.86MIVVD : INVIVYD INC $ -112.98MDOMH : DOMINARI HOLDINGS INC $ 3.67MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -2.82MFBIO : FORTRESS BIOTECH INC $ -2.66MENTA : ENANTA PHARMACEUTICALS INC $ 8.43MSGMO : SANGAMO THERAPEUTICS INC $ 12.06M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

CSBR - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -7.5M

Minimum

Mar 31, 2024

$ 7.43M

Maximum

Jun 30, 2025

$ 235.75K

Average

$ -77.5K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M